$14.74 arrow  Change: 0.38 %Chge: 2.61% Vol: 773,167
End Of Day Prices
High: 14.755 | Low: 14.29 | Open: 14.29 | Close: 14.74
52 Wk High: 18.64 | 52 Wk Low: 8.34 | Todays Pivot: 14.60
Sector: Healthcare and Pharmaceuticals add stock to watch list

VRX Chart

You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Related Healthcare and Pharmaceuticals Companies

Patterson Companies 33.89 red arrow 267,800
Allscripts Healthcare Solutns 13.04 green arrow 178,688
Mednax 57.3275 green arrow 23,241
Waters 134.26 red arrow 20,124
Allscripts Healthcare Solutns 10.5 red arrow 51,508
Carefusion 27.58 red arrow 811,400
Health Mgmt Assoc 6.105 green arrow 193,255
Merck 44.965 green arrow 868,278

Above is a small selection of related companies to Valeant Pharmaceuticals Intl I which compete alongside VRX within the Healthcare and Pharmaceuticals sector. To see more related companies to VRX, view our stock market today information page.

Online News For Valeant Pharmaceuticals Intl I

Valeant Pharmaceuticals Intl Inc (VRX) Gets a Price Target Trim on Uncertainty Circling Legal Liabilities

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) may have impressed some on the Street with its third quarter beat that surpassed Street-wide expectations, but one cautious expert, while optimistic, worries what will come of the troubled giant’s legal ...

Despite Valeant Improvement, VRX Stock Price Is Still Too High

Give credit where credit is due. New CEO Joe Papa has done a nice job in his efforts to turn around Valeant Pharmaceuticals Intl Inc (NYSE:VRX). So far, it hasn’t done much for the VRX stock price, which is basically flat so far in 2017. But flat ...

Israel “Izzy” Englander isn’t afraid to go against the market on TEVA, VRX and ACAD.

Israel “Izzy” Englander kick-started Millennium Management 28 years ago, taking the firm from $35 million to now $34 billion in assets. In the third quarter, Englander made some unusual decisions, boosting stocks like Teva Pharmaceutical Industries ...

OPTIS releases VRX 2018, placing driving simulation at the heart of smart lighting

New version of virtul reality software enables transportation industry to virtually test advanced headlight systems and provide smarter, safer lighting to their customers San Jose Calif. - Nov.9, 2017 - OPTIS, Virtual Reality prototyping software Editor ...

With Shares Trading down at $15.06 (VRX) Valeant Pharmaceuticals Completes Sale…

The stock increased 0.20% or $0.03 on November 10, reaching $15.38. Corporate insiders own 5.87% of the company's stock. Tower Research Capital LLC TRC raised its stake in Valeant Pharmaceuticals International by 6.7% in the second quarter. According to 21 ...

Want To Add This Quote To Your Site?

With our stock widgets you can add a Valeant Pharmaceuticals Intl I quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for VRX to choose from. Visit here to build your stock quote widget »